Artificial Shrinkage of Fresh Blastocysts

NCT ID: NCT02988544

Last Updated: 2024-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-20

Study Completion Date

2022-02-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to determine if collapsing an embryo (or making it fold compactly by taking away its fluid) before the transfer in the uterine cavity improves pregnancy rates in assisted reproductive technology (ART).

Women coming to our ART center will be randomized in two groups : the collapsing group and a control group.

Pregnancy rates will be compared in the two groups. A biomarker (cell free DNA) will also be determined in each group and correlated to pregnancy occurrence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective randomized study designed to determine if artificial shrinkage (AS) before transfer of embryos impact clinical pregnancy rate in single blastocyst embryo transfer (SBET) cycle. Women elected for SBET will be randomized on transfer day in two arms:the AS group where blastocoelic cavity is artificially reduced by a laser pulse prior to transfer and a control group.

Clinical pregnancy rates will be compared. Secondarily, rate of monozygotic twin pregnancy and cell free DNA concentration in culture medium will be evaluated in the two groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility Assisted Reproductive Technology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Artificial shrinkage (AS) group

The Artificial shrinkage group where blastocoelic cavity is artificially reduced by a laser pulse prior to transfer

Group Type EXPERIMENTAL

Artificial shrinkage

Intervention Type PROCEDURE

Artificial shrinkage of blastocyst

Control group

No intervention on blastocoelic

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artificial shrinkage

Artificial shrinkage of blastocyst

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Couple eligible for a transfer of a single embryo at the blastocyst stage
* Available couple for a follow up of 12 months

Exclusion Criteria

* Attempt with frozen embryo or frozen oocyte
* Attempt with a pre-implantation diagnosis
* Patient has not signed informed consent
* Couple in a period of exclusion determined by a previous study
* Couple under legal protection, guardianship or guardianship
Minimum Eligible Age

18 Years

Maximum Eligible Age

43 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anna AG GALA, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Montpellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montpellier University Hospital

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Czamanski-Cohen J, Sarid O, Cwikel J, Lunenfeld E, Douvdevani A, Levitas E, Har-Vardi I. Increased plasma cell-free DNA is associated with low pregnancy rates among women undergoing IVF-embryo transfer. Reprod Biomed Online. 2013 Jan;26(1):36-41. doi: 10.1016/j.rbmo.2012.09.018. Epub 2012 Oct 4.

Reference Type BACKGROUND
PMID: 23182744 (View on PubMed)

D'Alessandro A, Federica G, Palini S, Bulletti C, Zolla L. A mass spectrometry-based targeted metabolomics strategy of human blastocoele fluid: a promising tool in fertility research. Mol Biosyst. 2012 Apr;8(4):953-8. doi: 10.1039/c1mb05358b. Epub 2011 Oct 21.

Reference Type BACKGROUND
PMID: 22020776 (View on PubMed)

Fanchin R, Ayoubi JM. Uterine dynamics: impact on the human reproduction process. Reprod Biomed Online. 2009;18 Suppl 2:57-62. doi: 10.1016/s1472-6483(10)60450-6.

Reference Type BACKGROUND
PMID: 19406033 (View on PubMed)

Gala A, Ferrieres A, Assou S, Monforte M, Bringer-Deutsch S, Vintejoux E, Vincens C, Brunet C, Hamamah S. [Effects of artificial shrinkage prior to vitrification in a closed system: a randomized controlled trial]. Gynecol Obstet Fertil. 2014 Nov;42(11):772-8. doi: 10.1016/j.gyobfe.2014.09.006. Epub 2014 Oct 16. French.

Reference Type BACKGROUND
PMID: 25442824 (View on PubMed)

Gianaroli L, Magli MC, Pomante A, Crivello AM, Cafueri G, Valerio M, Ferraretti AP. Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot study. Fertil Steril. 2014 Dec;102(6):1692-9.e6. doi: 10.1016/j.fertnstert.2014.08.021. Epub 2014 Sep 23.

Reference Type BACKGROUND
PMID: 25256935 (View on PubMed)

Hammadeh ME, Fischer-Hammadeh C, Ali KR. Assisted hatching in assisted reproduction: a state of the art. J Assist Reprod Genet. 2011 Feb;28(2):119-28. doi: 10.1007/s10815-010-9495-3. Epub 2010 Nov 2.

Reference Type BACKGROUND
PMID: 21042844 (View on PubMed)

Hur YS, Park JH, Ryu EK, Yoon HJ, Yoon SH, Hur CY, Lee WD, Lim JH. Effect of artificial shrinkage on clinical outcome in fresh blastocyst transfer cycles. Clin Exp Reprod Med. 2011 Jun;38(2):87-92. doi: 10.5653/cerm.2011.38.2.87. Epub 2011 Jun 30.

Reference Type BACKGROUND
PMID: 22384424 (View on PubMed)

Iwayama H, Hochi S, Yamashita M. In vitro and in vivo viability of human blastocysts collapsed by laser pulse or osmotic shock prior to vitrification. J Assist Reprod Genet. 2011 Apr;28(4):355-61. doi: 10.1007/s10815-010-9522-4. Epub 2010 Dec 9.

Reference Type BACKGROUND
PMID: 21152966 (View on PubMed)

Kato S, Janku F. Cell-free DNA as a novel marker in cancer therapy. Biomark Med. 2015;9(7):703-12. doi: 10.2217/bmm.15.38.

Reference Type BACKGROUND
PMID: 26174844 (View on PubMed)

Kawachiya S, Bodri D, Shimada N, Kato K, Takehara Y, Kato O. Blastocyst culture is associated with an elevated incidence of monozygotic twinning after single embryo transfer. Fertil Steril. 2011 May;95(6):2140-2. doi: 10.1016/j.fertnstert.2010.12.018. Epub 2011 Jan 7.

Reference Type BACKGROUND
PMID: 21215395 (View on PubMed)

Khalaf Y, El-Toukhy T, Coomarasamy A, Kamal A, Bolton V, Braude P. Selective single blastocyst transfer reduces the multiple pregnancy rate and increases pregnancy rates: a pre- and postintervention study. BJOG. 2008 Feb;115(3):385-90. doi: 10.1111/j.1471-0528.2007.01584.x.

Reference Type BACKGROUND
PMID: 18190376 (View on PubMed)

Magli MC, Gianaroli L, Ferraretti AP. Chromosomal abnormalities in embryos. Mol Cell Endocrinol. 2001 Oct 22;183 Suppl 1:S29-34. doi: 10.1016/s0303-7207(01)00574-3.

Reference Type BACKGROUND
PMID: 11576729 (View on PubMed)

MANDEL P, METAIS P. [Nuclear Acids In Human Blood Plasma]. C R Seances Soc Biol Fil. 1948 Feb;142(3-4):241-3. No abstract available. French.

Reference Type BACKGROUND
PMID: 18875018 (View on PubMed)

Palini S, Galluzzi L, De Stefani S, Bianchi M, Wells D, Magnani M, Bulletti C. Genomic DNA in human blastocoele fluid. Reprod Biomed Online. 2013 Jun;26(6):603-10. doi: 10.1016/j.rbmo.2013.02.012. Epub 2013 Mar 13.

Reference Type BACKGROUND
PMID: 23557766 (View on PubMed)

Scalici E, Traver S, Molinari N, Mullet T, Monforte M, Vintejoux E, Hamamah S. Cell-free DNA in human follicular fluid as a biomarker of embryo quality. Hum Reprod. 2014 Dec;29(12):2661-9. doi: 10.1093/humrep/deu238. Epub 2014 Sep 29.

Reference Type BACKGROUND
PMID: 25267787 (View on PubMed)

Schieve LA, Meikle SF, Peterson HB, Jeng G, Burnett NM, Wilcox LS. Does assisted hatching pose a risk for monozygotic twinning in pregnancies conceived through in vitro fertilization? Fertil Steril. 2000 Aug;74(2):288-94. doi: 10.1016/s0015-0282(00)00602-6.

Reference Type BACKGROUND
PMID: 10927046 (View on PubMed)

Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011 Jun;11(6):426-37. doi: 10.1038/nrc3066. Epub 2011 May 12.

Reference Type BACKGROUND
PMID: 21562580 (View on PubMed)

Sharma VK, Vouros P, Glick J. Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids. Int J Mass Spectrom. 2011 Jul;304(2-3):172-183. doi: 10.1016/j.ijms.2010.10.003.

Reference Type BACKGROUND
PMID: 21765648 (View on PubMed)

Son WY, Yoon SH, Yoon HJ, Lee SM, Lim JH. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum Reprod. 2003 Jan;18(1):137-9. doi: 10.1093/humrep/deg029.

Reference Type BACKGROUND
PMID: 12525454 (View on PubMed)

Stigliani S, Anserini P, Venturini PL, Scaruffi P. Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation. Hum Reprod. 2013 Oct;28(10):2652-60. doi: 10.1093/humrep/det314. Epub 2013 Jul 25.

Reference Type BACKGROUND
PMID: 23887072 (View on PubMed)

Stigliani S, Persico L, Lagazio C, Anserini P, Venturini PL, Scaruffi P. Mitochondrial DNA in Day 3 embryo culture medium is a novel, non-invasive biomarker of blastocyst potential and implantation outcome. Mol Hum Reprod. 2014 Dec;20(12):1238-46. doi: 10.1093/molehr/gau086. Epub 2014 Sep 17.

Reference Type BACKGROUND
PMID: 25232043 (View on PubMed)

Traver S, Scalici E, Mullet T, Molinari N, Vincens C, Anahory T, Hamamah S. Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes. PLoS One. 2015 Aug 19;10(8):e0136172. doi: 10.1371/journal.pone.0136172. eCollection 2015.

Reference Type BACKGROUND
PMID: 26288130 (View on PubMed)

Van Landuyt L, Polyzos NP, De Munck N, Blockeel C, Van de Velde H, Verheyen G. A prospective randomized controlled trial investigating the effect of artificial shrinkage (collapse) on the implantation potential of vitrified blastocysts. Hum Reprod. 2015 Nov;30(11):2509-18. doi: 10.1093/humrep/dev218. Epub 2015 Sep 12.

Reference Type BACKGROUND
PMID: 26364080 (View on PubMed)

Vanderzwalmen P, Bertin G, Debauche Ch, Standaert V, van Roosendaal E, Vandervorst M, Bollen N, Zech H, Mukaida T, Takahashi K, Schoysman R. Births after vitrification at morula and blastocyst stages: effect of artificial reduction of the blastocoelic cavity before vitrification. Hum Reprod. 2002 Mar;17(3):744-51. doi: 10.1093/humrep/17.3.744.

Reference Type BACKGROUND
PMID: 11870130 (View on PubMed)

Warton K, Samimi G. Methylation of cell-free circulating DNA in the diagnosis of cancer. Front Mol Biosci. 2015 Apr 22;2:13. doi: 10.3389/fmolb.2015.00013. eCollection 2015.

Reference Type BACKGROUND
PMID: 25988180 (View on PubMed)

Wu CL, Li HG, Zhu CH. [Advances in the studies of cell-free seminal DNA]. Zhonghua Nan Ke Xue. 2013 Jul;19(7):652-6. Chinese.

Reference Type BACKGROUND
PMID: 23926686 (View on PubMed)

Brouillet S, Gala A, Barry F, Anav M, Ferrieres-Hoa A, Andreeva A, Molinari N, Gaspari L, Loup V, Anahory T, Hamamah S. Artificial shrinkage before fresh blastocyst transfer and IVF outcomes: a pilot randomized controlled study. Reprod Biomed Online. 2024 Aug;49(2):103941. doi: 10.1016/j.rbmo.2024.103941. Epub 2024 Mar 8.

Reference Type RESULT
PMID: 38824764 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL16_0267

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.